Biomerica (BMRA) Receivables - Other (2018 - 2026)

Biomerica has disclosed Receivables - Other across 9 years of filings, most recently posting $978000.0 for Q1 2026.

• Receivables - Other for Q1 2026 came in at $978000.0, down 24.36% year-over-year; the trailing twelve-month figure through Feb 2026 was $978000.0 (down 24.36% YoY), and the FY2025 annual result was $757000.0, down 21.64% from the prior year.
• Receivables - Other came in at $978000.0 for Q1 2026 at Biomerica, down from $1.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $1.6 million in Q3 2024 to a low of $751000.0 in Q2 2023.
• The 5-year median for Receivables - Other is $1.1 million (2023), against an average of $1.1 million.
• Across the five-year window, Receivables - Other slumped 59.55% in 2022 and rose 28.63% in 2024, its largest moves.
• Biomerica's Receivables - Other stood at $927000.0 in 2022, then rose by 17.48% to $1.1 million in 2023, then gained by 24.24% to $1.4 million in 2024, then slipped by 22.91% to $1.0 million in 2025, then declined by 6.23% to $978000.0 in 2026.
• The last three Receivables - Other figures came in at $978000.0 (Q1 2026), $1.0 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.